In a cellular PD model, gain-of-function mutations in LRRK2 caused lysosomal sequestration of endogenous Rab8a, which was reversed by pharmacological inhibition of LRRK2 (Mamais et al., 2021). The gene discussed is RAB8A; the disease is Parkinson disease.